MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA type-c
Clinical Status
Preclinical — early human studies beginning.
Mechanism of Action
Encoded by mitochondrial DNA and acts as a mitokine. Activates AMPK, improves glucose uptake, enhances fatty acid oxidation, and has systemic metabolic regulatory effects.
Dosing Defaults
Dose
5-10 mg weekly
Frequency
1-3x weekly
Administration
Subcutaneous injection
Timing
Morning or pre-workout
Food
fasted
Duration
Variable by protocol
Dose range: 5-15 mg per week
Pre-workout timing enhances metabolic benefits.
Side Effects
- •Injection site reactions
- •Palpitations
- •Nausea and bloating
- •Fatigue
- •May trigger histamine release
Contraindications & Warnings
- •Not medical advice
Compare
Compare MOTS-c with another peptide side-by-side.
Ad
Related Anti-Aging & Longevity Peptides
This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.